Logo
Homepage
Explore Our Models
My Cart
Contact
Subscribe
Models
Genetically Engineered Animals
Knockout Mice
Knockout Rats
Knockin Mice
Knockin Rats
Transgenic Mice
Transgenic Rats
Model Generation Techniques
Turboknockout<sup>®</sup> Gene Targeting
ES Cell Gene Targeting
Targeted Gene Editing
Regular Transgenic
PiggyBac Transgenesis
BAC Transgenic
Research Models
HUGO-GT™ Humanized Mice
Cre Mouse Lines
Humanized Target Gene Models
Metabolic Disease Models
Ophthalmic Disease Models
Neurological Disease Models
Autoimmune Disease Models
Immunodeficient Mouse Models
Humanized Immune System Mouse Models
Oncology & Immuno-oncology Models
Covid-19 Mouse Models
MouseAtlas Model Library
Knockout Cell Line Product Catalog
Tumor Cell Line Product Catalog
AAV Standard Product Catalog
Animal Supporting Services
Breeding Services
Cryopreservation & Recovery
Phenotyping Services
BAC Modification
Custom Cell Line Models
Induced Pluripotent Stem Cells (iPSCs)
Knockout Cell Lines
Knockin Cell Lines
Point Mutation Cell Lines
Overexpression Cell Lines
Virus Packaging
Adeno-associated Virus (AAV) Packaging
Lentivirus Packaging
Adenovirus Packaging
CRO Services
By Therapeutic Area
Oncology
Ophthalmology
Neuroscience
Metabolic & Cardiovascular Diseases
Autoimmune & Inflammatory
By Drug Type
AI-Powered AAV Discovery
Gene Therapy
Oligonucleotide Therapy
Antibody Therapy
Cell Immunotherapy
Resources
Promotion
Events & Webinars
Newsroom
Blogs & Insights
Resource Vault
Reference Databases
Peer-Reviewed Citations
Rare Disease Data Center
AbSeek
Cell iGeneEditor™ System
OriCell
Quality
Facility Overview
Animal Health & Welfare
Health Reports
About Us
Corporate Overview
Our Partners
Careers
Contact Us
Login
Request a Product Quote
Select products from our catalogs and submit your request. Our team will get back to you with detailed information.
Full Name
Email
Phone Number
Organization
Job Role
Country
Catalog Type
Product Name
Additional Comments
Cyagen values your privacy. We’d like to keep you informed about our latest offerings and insights. Your preferences:
You may unsubscribe from these communications at any time. See our Privacy Policy for details on opting out and data protection.
By clicking the button below, you consent to allow Cyagen to store and process the personal information submitted in this form to provide you the content requested.
C57BL/6NCya-Pim2em1/Cya
Common Name:
Pim2-KO
Product ID:
S-KO-03657
Background:
C57BL/6NCya
Product Type
Age
Genotype
Sex
Quantity
Price:
Contact for Pricing
Basic Information
Strain Name
Pim2-KO
Strain ID
KOCMP-18715-Pim2-B6N-VA
Gene Name
Pim2
Product ID
S-KO-03657
Gene Alias
DXCch3; Pim-2
Background
C57BL/6NCya
NCBI ID
18715
Modification
Conventional knockout
Chromosome
X
Phenotype
MGI:97587
Document
Click here to download >>
Application
--
More
Rare Disease Data Center >>
Note
Note: When using this mouse strain in a publication, please cite “C57BL/6NCya-Pim2em1/Cya mice (Catalog S-KO-03657) were purchased from Cyagen.”
Strain Description
Ensembl Number
ENSMUST00000033495
NCBI RefSeq
NM_138606
Target Region
Exon 3~4
Size of Effective Region
~2.0 kb
Detailed Document
Click here to download >>
Overview of Gene Research
Pim2, short for proviral integration site for Moloney murine leukemia virus 2, is a serine/threonine protein kinase functioning as an oncogene. It promotes transcriptional activation of genes related to cell survival, proliferation, and cell-cycle progression. Pim2 is involved in multiple signaling pathways such as p38 MAPK/Erk, NF-κB, and Toll-like receptor 2 (TLR2)/myeloid differentiation primary response 88 (MyD88) pathways [1,2,6]. Genetic models, like KO/CKO mouse models, are valuable for studying its functions.

In hepatocellular carcinoma, Pim2 induced by pro-inflammatory macrophages suppresses immunotherapy efficacy. IL1β from IFNγ-polarized tumor macrophages triggers Pim2 expression in cancer cells via p38 MAPK/Erk and NF-κB signaling, and Pim2 + cancer cells resist T-cell cytotoxicity and immunotherapy [1].

In ovarian endometriosis, Pim2 promotes development by enhancing glycolysis and fibrosis, and Pim2 inhibitor SMI-4a can inhibit this process. A Pim2 knockout mouse model was established to demonstrate its role in vivo [3].

In solid tumors, Pim2 promotes cancer progression. The pan-PIM inhibitor JP11646 induces apoptosis by PIM2 protein degradation in vitro and in vivo in mouse xenograft solid cancer models [4].

In endometriosis, Pim2 phosphorylates PFKFB4 to promote anaerobic glycolysis and cell proliferation [5].

In breast cancer, Pim2 phosphorylates USP27X to promote glycolysis and cancer progression [7].

In inflammatory arthritis, conditional knockout of Pim2 in macrophages or using Pim2 inhibitor HJ-PI01 attenuates arthritis development by inhibiting M1 macrophage polarization [8].

In summary, Pim2 is crucial in processes like cell survival, proliferation, and glycolysis regulation. KO/CKO mouse models have revealed its role in diseases such as hepatocellular carcinoma, endometriosis, solid tumors, breast cancer, and inflammatory arthritis, providing insights for potential therapeutic strategies targeting Pim2 in these disease areas.

References:

1. Wang, Jun-Cheng, Chen, Dong-Ping, Lu, Shi-Xun, Chen, Min-Shan, Zhou, Zhong-Guo. . PIM2 Expression Induced by Proinflammatory Macrophages Suppresses Immunotherapy Efficacy in Hepatocellular Carcinoma. In Cancer research, 82, 3307-3320. doi:10.1158/0008-5472.CAN-21-3899. https://pubmed.ncbi.nlm.nih.gov/35802648/

2. Wang, Yixin, Xiu, Jing, Ren, Chune, Yu, Zhenhai. 2021. Protein kinase PIM2: A simple PIM family kinase with complex functions in cancer metabolism and therapeutics. In Journal of Cancer, 12, 2570-2581. doi:10.7150/jca.53134. https://pubmed.ncbi.nlm.nih.gov/33854618/

3. Wang, Mengxue, Fan, Ruiqi, Jiang, Junyi, Yu, Zhenhai, Yang, Tingting. 2023. PIM2 Promotes the Development of Ovarian Endometriosis by Enhancing Glycolysis and Fibrosis. In Reproductive sciences (Thousand Oaks, Calif.), 30, 2692-2702. doi:10.1007/s43032-023-01208-w. https://pubmed.ncbi.nlm.nih.gov/37059967/

4. Katsuta, Eriko, Gil-Moore, Malgorzata, Moore, Justine, Takabe, Kazuaki, Opyrchal, Mateusz. 2022. Targeting PIM2 by JP11646 results in significant antitumor effects in solid tumors. In International journal of oncology, 61, . doi:10.3892/ijo.2022.5404. https://pubmed.ncbi.nlm.nih.gov/35920189/

5. Lu, Chao, Qiao, Pengyun, Fu, Ruihai, Ren, Chune, Yu, Zhenhai. 2022. Phosphorylation of PFKFB4 by PIM2 promotes anaerobic glycolysis and cell proliferation in endometriosis. In Cell death & disease, 13, 790. doi:10.1038/s41419-022-05241-6. https://pubmed.ncbi.nlm.nih.gov/36109523/

6. Ding, Juncai, Yang, Xiufang, Huang, Huijuan, Wang, Bo. 2022. Role of PIM2 in acute lung injury induced by sepsis. In Experimental and therapeutic medicine, 24, 543. doi:10.3892/etm.2022.11480. https://pubmed.ncbi.nlm.nih.gov/35978927/

7. Han, Xue, Ren, Chune, Lu, Chao, Liu, Lan, Yu, Zhenhai. 2024. Phosphorylation of USP27X by PIM2 promotes glycolysis and breast cancer progression via deubiquitylation of MYC. In Oncogene, 43, 2493-2503. doi:10.1038/s41388-024-03097-y. https://pubmed.ncbi.nlm.nih.gov/38969771/

8. Xu, Xiaojun, Xu, Peitao, Shen, Guozhen, Shen, Huiyong, Li, Jinteng. 2025. Targeting macrophage polarization by inhibiting Pim2 alleviates inflammatory arthritis via metabolic reprogramming. In Cellular & molecular immunology, 22, 418-436. doi:10.1038/s41423-025-01268-9. https://pubmed.ncbi.nlm.nih.gov/40000906/

Quality Control Standard
Sperm Test

Pre-cryopreservation: Measurement of sperm concentration, determination of sperm viability.

Post-cryopreservation: A vial of cryopreserved sperms is selected for in-vitro fertilization from each batch.

Environmental Standards:SPF
Available Region:Global
Source:Cyagen
Model Library
Model Library
Resources
Resources
Animal Quality
Animal Quality
Get Support
Get Support
Address:
2255 Martin Avenue, Suite E Santa Clara, CA 95050-2709, US
Tel:
800-921-8930 (8-6pm PST)
+1408-963-0306 (lnt’l)
Fax:
408-969-0338
Email:
animal-service@cyagen.com
service@cyagen.us
CRO Services
OncologyOphthalmologyNeuroscienceMetabolic & CardiovascularAutoimmune & InflammatoryGene TherapyAntibody Therapy
About Us
Corporate OverviewOur PartnersCareersContact Us
Social Media
Disclaimer: Pricing and availability of our products and services vary by region. Listed prices are applicable to the specific countries. Please contact us for more information.
Copyright © 2025 Cyagen. All rights reserved.
Privacy Policy
Site Map
Stay Updated with the Latest from Cyagen
Get the latest news on our research models, CRO services, scientific resources, and special offers—tailored to your research needs and delivered straight to your inbox.
Full Name
Email
Organization
Country
Areas of Interest